Distinct Clinical and Immunologic Profiles in Severe Malarial Anemia and Cerebral Malaria in Zambia
Open Access
- 14 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 203 (2) , 211-219
Abstract
Background. The mechanisms of severe malarial anemia and cerebral malaria, which are extreme manifestations of Plasmodium falciparum malaria, are not fully understood. Methods. Children aged n = 72), cerebral malaria (n = 28), or uncomplicated malaria (n = 66) were studied prospectively. Children with overlapping severe anemia and cerebral malaria were excluded. Results. Low interleukin 10 concentrations had the strongest association with severe anemia (standard β = .61; P < .001) followed by high tumor necrosis factor α and sFas concentrations, low weight-for-age z scores, presence of stool parasites, and splenomegaly (standard β = .15–.25; P ≤ .031); most of these factors were also associated with lower reticulocytes. Greater parasitemia was associated with higher interleukin 10 and tumor necrosis factor α concentrations, whereas sulfadoxizole/pyrimethamine therapy and lower weight-for-age z scores were associated with lower interleukin 10 levels. Thrombocytopenia and elevated tissue plasminogen activator inhibitor 1 levels had the strongest associations with cerebral malaria (standard β = .37 or .36; P < .0001), followed by exposure to traditional herbal medicine and hemoglobinuria (standard β = .21–.31; P ≤ .006). Conclusions. Predictors of severe malarial anemia (altered immune responses, poor nutrition, intestinal parasites, and impaired erythropoiesis) differed from those of cerebral malaria (thrombocytopenia, herbal medicine, and intravascular hemolysis). Improved preventive and therapeutic measures may need to consider these differences.Keywords
This publication has 51 references indexed in Scilit:
- Cardiac function and hemodynamics in Kenyan children with severe malariaCritical Care Medicine, 2010
- Tumor Necrosis Factor and Lymphotoxin‐α Polymorphisms and Severe Malaria in African PopulationsThe Journal of Infectious Diseases, 2009
- Malarial anemia and STAT6Haematologica, 2009
- Polymorphic Variability in the Interleukin (IL)–1β Promoter Conditions Susceptibility to Severe Malarial Anemia and Functional Changes in IL‐1β ProductionThe Journal of Infectious Diseases, 2008
- Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malariaJournal of Experimental Medicine, 2007
- Vascular Functions of the Plasminogen Activation SystemArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Cerebrovascular disease associated with sickle cell pulmonary hypertensionAmerican Journal of Hematology, 2006
- A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemiaJournal of Experimental Medicine, 2006
- A single-nucleotide substitution from C to T at position −1055 in the IL-13 promoter is associated with protection from severe malaria in ThailandGenes & Immunity, 2003
- Relationship between Plasma Interleukin-12 (IL-12) and IL-18 Levels and Severe Malarial Anemia in an Area of Holoendemicity in Western KenyaClinical and Vaccine Immunology, 2003